drugset / Trial / NCT01814670
Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
NaSingle-groupOpen-labelTreatment
Summary
A study to evaluate safety and efficacy of treatment with botulinum toxin Type A (BOTOX®) in Chinese patients with moderate to severe frown lines (Glabellar Rhytides) previously treated with facial laser resurfacing.
Timeline
- Start
- 2013-03-06
- Primary completion
- 2014-07-31
- Completion
- 2014-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 unknown | Other |
Indications
No indication recorded.